Guardant Financial Statements From 2010 to 2024

GH Stock  USD 20.63  2.67  14.87%   
Guardant Health financial statements provide useful quarterly and yearly information to potential Guardant Health investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Guardant Health financial statements helps investors assess Guardant Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Guardant Health's valuation are summarized below:
Gross Profit
293.2 M
Profit Margin
(0.85)
Market Capitalization
2.2 B
Enterprise Value Revenue
4.1462
Revenue
563.9 M
We have found one hundred twenty available fundamental trends for Guardant Health, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Guardant Health regular fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year.
Check Guardant Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guardant main balance sheet or income statement drivers, such as Tax Provision of 719.2 K, Net Interest Income of 34.4 M or Interest Income of 37.1 M, as well as many exotic indicators such as Price To Sales Ratio of 5.1, Dividend Yield of 0.0019 or Operating Cycle of 136. Guardant financial statements analysis is a perfect complement when working with Guardant Health Valuation or Volatility modules.
  
This module can also supplement Guardant Health's financial leverage analysis and stock options assessment as well as various Guardant Health Technical models . Check out the analysis of Guardant Health Correlation against competitors.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

Guardant Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.4 B1.8 B796 M
Slightly volatile
Short and Long Term Debt Total685.2 M1.4 B384.7 M
Slightly volatile
Total Current Liabilities112 M205.9 M67.5 M
Slightly volatile
Total Stockholder Equity150.7 M158.7 M297.4 M
Slightly volatile
Other Liabilities6.7 M8.3 M7.2 M
Pretty Stable
Property Plant And Equipment Net163.8 M302.7 M95.4 M
Slightly volatile
Current Deferred Revenue12.2 M18 M7.5 M
Slightly volatile
Accounts Payable39.5 M51.7 M23.1 M
Slightly volatile
Cash1.2 B1.1 B292.1 M
Slightly volatile
Non Current Assets Total402.7 M439.3 M227.5 M
Slightly volatile
Non Currrent Assets Other130.4 M124.2 M27.3 M
Slightly volatile
Other Assets44 M41.9 M14.4 M
Slightly volatile
Long Term Debt776.5 M1.1 B448.2 M
Slightly volatile
Cash And Short Term Investments847.8 M1.2 B505.7 M
Slightly volatile
Net Receivables60.1 M88.8 M34.5 M
Slightly volatile
Common Stock Shares Outstanding92.9 M112 M79.5 M
Slightly volatile
Short Term Investments33.3 M35.1 M238.6 M
Slightly volatile
Long Term Debt Total1.4 B1.3 B445.7 M
Slightly volatile
Liabilities And Stockholders Equity1.4 B1.8 B796 M
Slightly volatile
Non Current Liabilities Total1.5 B1.4 B447.7 M
Slightly volatile
Capital Surpluse1.1 BB694.2 M
Slightly volatile
Capital Lease Obligations224.5 M213.8 M65.5 M
Slightly volatile
Inventory65 M61.9 M18.9 M
Slightly volatile
Other Current Assets20.6 M27.7 M12 M
Slightly volatile
Other Stockholder Equity1.3 B2.3 B725.9 M
Slightly volatile
Total Liabilities1.7 B1.6 B522.1 M
Slightly volatile
Property Plant And Equipment Gross451.5 M430 M123.1 M
Slightly volatile
Short and Long Term Debt563.4 K593.1 K8.3 M
Slightly volatile
Preferred Stock Total Equity374 M575 M347.3 M
Slightly volatile
Total Current Assets956.1 M1.3 B568.5 M
Slightly volatile
Non Current Liabilities Other100.8 M96 M18.5 M
Slightly volatile
Short Term Debt29.3 M27.9 M7.1 M
Slightly volatile
Property Plant Equipment106.4 M193.1 M70.2 M
Slightly volatile
Net Working Capital950.8 M1.1 B571 M
Slightly volatile
Intangible Assets13.1 MM10.5 M
Slightly volatile
Warrants54.5 M65.7 M47.8 M
Slightly volatile
Common Stock Total Equity800900980
Slightly volatile
Deferred Long Term Liabilities6.3 M7.1 M7.7 M
Slightly volatile
Capital Stock800900980
Slightly volatile
Common Stock800900980
Slightly volatile
Good Will2.6 MM3.2 M
Slightly volatile

Guardant Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income37.1 M35.4 M7.9 M
Slightly volatile
Interest Expense2.8 M2.6 M2.8 M
Pretty Stable
Selling General Administrative118.7 M155.8 M69.4 M
Slightly volatile
Selling And Marketing Expenses149 M295.2 M92.7 M
Slightly volatile
Total Revenue282.4 M563.9 M165.9 M
Slightly volatile
Gross Profit177 M336.9 M98.9 M
Slightly volatile
Other Operating Expenses566.9 M1.1 B340.3 M
Slightly volatile
Research Development383.3 M365.1 M118.3 M
Slightly volatile
Cost Of Revenue238.4 M227.1 M75.8 M
Slightly volatile
Total Operating Expenses461.5 M899.4 M273.3 M
Slightly volatile
Reconciled Depreciation22.5 M42.9 M13.5 M
Slightly volatile
Preferred Stock And Other Adjustments880 K990 K1.1 M
Slightly volatile

Guardant Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation70.2 M90.8 M39.5 M
Slightly volatile
Begin Period Cash Flow255.9 M141.6 M142.8 M
Slightly volatile
Depreciation45 M42.9 M14.3 M
Slightly volatile
Capital Expenditures38.4 M20.5 M21.9 M
Slightly volatile
Change To Netincome70.3 M119.9 M43.8 M
Slightly volatile
Dividends Paid10.3 M20.5 M7.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.15.371654.0137
Slightly volatile
Dividend Yield0.00190.0020.0022
Slightly volatile
Operating Cycle136157138
Slightly volatile
Price Book Value Ratio13.7819.0921.5369
Slightly volatile
Days Of Payables Outstanding85.8183.176883.7621
Slightly volatile
Inventory Turnover5.023.66525.9634
Slightly volatile
Ebt Per Ebit1.080.85111.0157
Pretty Stable
Payables Turnover6.414.38826.3396
Pretty Stable
Company Equity Multiplier11.8211.25774.5846
Slightly volatile
Long Term Debt To Capitalization0.920.87780.3397
Slightly volatile
Cash Per Share7.210.43545.8171
Slightly volatile
Total Debt To Capitalization0.920.88040.3413
Slightly volatile
Debt Equity Ratio7.737.362.8121
Slightly volatile
Quick Ratio11.176.10648.9229
Pretty Stable
Dividend Paid And Capex Coverage Ratio8.3915.863312.9411
Slightly volatile
Net Income Per E B T0.81.00140.986
Slightly volatile
Cash Ratio3.225.50483.3046
Pretty Stable
Days Of Inventory Outstanding68.6199.585268.5859
Slightly volatile
Days Of Sales Outstanding92.0357.462470.962
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.011.0631.1597
Slightly volatile
Price To Book Ratio13.7819.0921.5369
Slightly volatile
Current Ratio11.626.5429.296
Pretty Stable
Fixed Asset Turnover2.511.8632.1805
Very volatile
Capital Expenditure Coverage Ratio8.1415.863312.803
Slightly volatile
Debt Ratio0.690.65380.2841
Slightly volatile
Price Sales Ratio5.15.371654.0137
Slightly volatile
Receivables Turnover3.836.3525.699
Slightly volatile
Asset Turnover0.160.31570.2059
Very volatile
Gross Profit Margin0.430.59740.3636
Slightly volatile
Price Fair Value13.7819.0921.5369
Slightly volatile

Guardant Fundamental Market Drivers

Cash And Short Term Investments1.2 B

Guardant Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Guardant Health Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Guardant Health income statement, its balance sheet, and the statement of cash flows. Guardant Health investors use historical funamental indicators, such as Guardant Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Guardant Health investors may use each financial statement separately, they are all related. The changes in Guardant Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Guardant Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Guardant Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Guardant Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue18 M12.2 M
Total Revenue563.9 M282.4 M
Cost Of Revenue227.1 M238.4 M
Ebit Per Revenue(1.00)(1.05)

Guardant Health Investors Sentiment

The influence of Guardant Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Guardant. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Guardant Health's public news can be used to forecast risks associated with an investment in Guardant. The trend in average sentiment can be used to explain how an investor holding Guardant can time the market purely based on public headlines and social activities around Guardant Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Guardant Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Guardant Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Guardant Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Guardant Health.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Guardant Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Guardant Health's short interest history, or implied volatility extrapolated from Guardant Health options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Guardant Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardant Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardant Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardant Health Stock:
Check out the analysis of Guardant Health Correlation against competitors.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.28)
Revenue Per Share
5.036
Quarterly Revenue Growth
0.222
Return On Assets
(0.18)
Return On Equity
(4.38)
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.